07-10-2020 14:00 via sltrib.com

Letter: Trump’s order won’t help most diabetics

Much ado has been made regarding President Trump’s executive order capping the costs of insulin. This executive order states that Medicare Part B/D drug prices will match the lowest cost of this drug sold in any OECD country. Many applaud the president for taking measures to make insulin more affordable (“It’s cheap as water now!”), stating that diabetics can access insulin for $35 a month and ignore that this only affects diabetics who are on Medicare who will have to pa
Read more »